Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8451)
All Articles published online
|
Aug 21, 2012 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nakagawa H, Maeda S. Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J Gastroenterol 2012; 18(31): 4071-4081 [PMID: 22919237 DOI: 10.3748/wjg.v18.i31.4071] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i31/4071.htm |
| Number | Citing Articles |
| 1 |
Jutaro Fukumoto, Ruan Cox, Itsuko Fukumoto, Young Cho, Prasanna Tamarapu Parthasarathy, Lakshmi Galam, Richard F. Lockey, Narasaiah Kolliputi, You-Yang Zhao. Deletion of ASK1 Protects against Hyperoxia-Induced Acute Lung Injury. PLOS ONE 2016; 11(1): e0147652 doi: 10.1371/journal.pone.0147652
|
| 2 |
Blanche Ip, Xiang-Dong Wang. Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention. Nutrients 2013; 6(1): 124 doi: 10.3390/nu6010124
|
| 3 |
Hongfang Ma, Na Xing, Lin Hou, Jianhua Wu, Ziyue Sha, Fujun Wang, Xiaohui Ji, Zhanjun Guo. Dicer Inhibits Hepatocellular Carcinoma by Inhibiting the Interleukin 6 Pathway. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-134381
|
| 4 |
Youyi Liu, Lijuan Liu, Yan Zhou, Ping Zhou, Qiujin Yan, Xiaobei Chen, Shuang Ding, Fan Zhu. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC. Clinical Cancer Research 2019; 25(13): 4141 doi: 10.1158/1078-0432.CCR-18-3510
|
| 5 |
Cong Zhang, Lei Sheng, Ming Yuan, Junjie Hu, Yan Meng, Yong Wu, Liang Chen, Huifan Yu, Shan Li, Guohua Zheng, Zhenpeng Qiu. Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met. Toxicology and Applied Pharmacology 2020; 392: 114918 doi: 10.1016/j.taap.2020.114918
|
| 6 |
Michel Desjarlais, Jonathan Pratt, Amine Lounis, Catherine Mounier, Khadidja Haidara, Borhane Annabi. Tetracycline Derivative Minocycline Inhibits Autophagy and Inflammation in Concanavalin-A-Activated Human Hepatoma Cells. Gene Regulation and Systems Biology 2014; 8 doi: 10.4137/GRSB.S13946
|
| 7 |
Dahai Wei, Yongyi Zeng, Xiaohua Xing, Hongzhi Liu, Minjie Lin, Xiao Han, Xiaolong Liu, Jingfeng Liu. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. Journal of Proteome Research 2016; 15(2): 487 doi: 10.1021/acs.jproteome.5b00838
|
| 8 |
Mark Williams, Xinhui Liu, Yueqi Zhang, Jake Reske, Devika Bahal, Trevor G. Gohl, Daniel Hollern, Elliot Ensink, Matti Kiupel, Rongcheng Luo, Rupali Das, Hua Xiao. NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21WAF1/CIP1 overexpression, which is reversed by metformin. Oncogene 2020; 39(19): 3821 doi: 10.1038/s41388-020-1256-x
|
| 9 |
Kun Lu, Guoyan Liu, Ling Yang, Fan Liu, Libin Gao, Jingxian Shi, Xiaoling Deng, Qifu Li, Donghui Xu, Songlin Shi. Sustainable inflammation transforms hepatic cells by causing oxidative stress injury and potential epithelial-mesenchymal transition. International Journal of Oncology 2016; 49(3): 971 doi: 10.3892/ijo.2016.3580
|
| 10 |
D. E. Marin, G. C. Pistol, M. Gras, M. Palade, I. Taranu. A comparison between the effects of ochratoxin A and aristolochic acid on the inflammation and oxidative stress in the liver and kidney of weanling piglets. Naunyn-Schmiedeberg's Archives of Pharmacology 2018; 391(10): 1147 doi: 10.1007/s00210-018-1538-9
|
| 11 |
Alberto Nicoletti, Francesca Romana Ponziani, Marco Biolato, Venanzio Valenza, Giuseppe Marrone, Gabriele Sganga, Antonio Gasbarrini, Luca Miele, Antonio Grieco. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World Journal of Gastroenterology 2019; 25(33): 4814-4834 doi: 10.3748/wjg.v25.i33.4814
|
| 12 |
Yan Mardian, Yoshihiko Yano, Neneng Ratnasari, Lina Choridah, Widya Wasityastuti, Nurhuda Hendra Setyawan, Yoshitake Hayashi. “Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study”. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1152-4
|
| 13 |
Yujie Pan, Yunkuo Li, Hongyu Fan, Huijuan Cui, Zhiyue Chen, Yunzhu Wang, Mengyu Jiang, Guixia Wang. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of hepatocellular carcinoma (HCC). Biomedicine & Pharmacotherapy 2024; 177: 117089 doi: 10.1016/j.biopha.2024.117089
|
| 14 |
Aurora Gazzillo, Camilla Volponi, Cristiana Soldani, Michela Anna Polidoro, Barbara Franceschini, Ana Lleo, Eduardo Bonavita, Matteo Donadon. Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies. Biomedicines 2023; 12(1): 26 doi: 10.3390/biomedicines12010026
|
| 15 |
Takefumi Kimura, Akira Kobayashi, Naoki Tanaka, Kenji Sano, Michiharu Komatsu, Naoyuki Fujimori, Tomoo Yamazaki, Soichiro Shibata, Yuki Ichikawa, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Akira Horiuchi, Hiromitsu Mori, Shuichi Wada, Kendo Kiyosawa, Shin‐ichi Miyagawa, Eiji Tanaka. Clinicopathological characteristics of non‐B non‐C hepatocellular carcinoma without past hepatitis B virus infection. Hepatology Research 2017; 47(5): 405 doi: 10.1111/hepr.12762
|
| 16 |
Francesca Faggioli, Eleonora Palagano, Luca Di Tommaso, Matteo Donadon, Veronica Marrella, Camilla Recordati, Stefano Mantero, Anna Villa, Paolo Vezzoni, Barbara Cassani. B lymphocytes limit senescence‐driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury. Hepatology 2018; 67(5): 1970 doi: 10.1002/hep.29636
|
| 17 |
Naoki Mizutani, Hayato Hikita, Yoshinobu Saito, Yuta Myojin, Katsuhiko Sato, Makiko Urabe, Tomohide Kurahashi, Yuto Shiode, Sadatsugu Sakane, Kazuhiro Murai, Yasutoshi Nozaki, Takahiro Kodama, Ryotaro Sakamori, Yuichi Yoshida, Tomohide Tatsumi, Tetsuo Takehara. Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(6): G958 doi: 10.1152/ajpgi.00370.2020
|
| 18 |
Ayman M. Mahmoud, Hanaa M. Mohammed, Sally M. Khadrawy, Sanaa R. Galaly. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation. Chemico-Biological Interactions 2017; 277: 146 doi: 10.1016/j.cbi.2017.09.015
|
| 19 |
Nam Su Oh, Jae Yeon Joung, Ji Young Lee, Youn Jeong Kim, Younghoon Kim, Sae Hun Kim. A synbiotic combination of Lactobacillus gasseri 505 and Cudrania tricuspidata leaf extract prevents hepatic toxicity induced by colorectal cancer in mice. Journal of Dairy Science 2020; 103(4): 2947 doi: 10.3168/jds.2019-17411
|
| 20 |
Anupam Bishayee. Inflammation and Cancer. Advances in Experimental Medicine and Biology 2014; 816: 401 doi: 10.1007/978-3-0348-0837-8_16
|
| 21 |
Chang-Liang Luo, Yuan Rong, Hao Chen, Wu-Wen Zhang, Long Wu, Diao Wei, Xiu-Qi Wei, Lie-Jun Mei, Fu-Bing Wang. A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819846632
|
| 22 |
HN Venkatesh, H Ravish, CR Wilma Delphine Silvia, H Srinivas. Molecular signature of the immune response to yoga therapy in stress-related chronic disease conditions: An insight. International Journal of Yoga 2020; 13(1): 9 doi: 10.4103/ijoy.IJOY_82_18
|
| 23 |
Yuan Luo, Xinyu Wen, Ling Wang, Jing Gao, Zi Wang, Chunyan Zhang, Pengjun Zhang, Chengrong Lu, Lianning Duan, Yaping Tian, Kum Kum Khanna. Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide‐Treated Human Hepatocellular Carcinoma Cell Line HepG2. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/7530853
|
| 24 |
C. Fron, J.-F. Blanc. Carcinoma hepatocelular. EMC - Tratado de Medicina 2018; 22(2): 1 doi: 10.1016/S1636-5410(18)89309-6
|
| 25 |
Xia Pu, Qing-Xi Guo, Han-An Long, Cheng-Wan Yang. Effects of mTOR-STAT3 on the migra=tion and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer. Asian Pacific Journal of Tropical Medicine 2014; 7(5): 368 doi: 10.1016/S1995-7645(14)60057-2
|
| 26 |
Nao Nagai, Yotaro Kudo, Daisuke Aki, Hayato Nakagawa, Koji Taniguchi. Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging. International Journal of Molecular Sciences 2021; 22(5): 2238 doi: 10.3390/ijms22052238
|
| 27 |
Hayato Nakagawa, Naoto Fujiwara, Ryosuke Tateishi, Toru Arano, Ryo Nakagomi, Mayuko Kondo, Tatsuya Minami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Yoshinari Asaoka, Yuji Kondo, Shuichiro Shiina, Haruhiko Yoshida, Kazuhiko Koike. Impact of serum levels of interleukin‐6 and adiponectin on all‐cause, liver‐related, and liver‐unrelated mortality in chronic hepatitis C patients. Journal of Gastroenterology and Hepatology 2015; 30(2): 379 doi: 10.1111/jgh.12719
|
| 28 |
Jiangfan Zhou, Li Liu, Xudong Hu, Rong Feng, Niannian Zhao, Li Zhang, Wenhao Hu, Jian Zhang, Shiyong Huang, Lin Liu, Wei Li, Yunfeng Shan, Jing Jin. Matrix metalloproteinase‐21 promotes metastasis via increasing the recruitment and M2 polarization of macrophages in HCC. Cancer Science 2023; 114(2): 423 doi: 10.1111/cas.15368
|
| 29 |
Hayato Nakagawa, Yuki Hayata, Tomoharu Yamada, Satoshi Kawamura, Nobumi Suzuki, Kazuhiko Koike. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer. International Journal of Molecular Sciences 2018; 19(6): 1745 doi: 10.3390/ijms19061745
|
| 30 |
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary Cancers. Trends in Cancer 2021; 7(7): 606 doi: 10.1016/j.trecan.2021.01.012
|
| 31 |
Tao Ouyang, Xuefeng Kan, Chuansheng Zheng. Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.898964
|
| 32 |
Francesca Romana Ponziani, Alberto Nicoletti, Antonio Gasbarrini, Maurizio Pompili. Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 2019; 11 doi: 10.1177/1758835919848184
|
| 33 |
Hayato Nakagawa. How Endoplasmic Reticulum Stress Contributes to Obesity-Driven Hepatic Tumorigenesis. Hepatic Oncology 2015; 2(3): 209 doi: 10.2217/hep.15.11
|
| 34 |
Janaki K Iyer, Mamta Kalra, Anil Kaul, Mark E Payton, Rashmi Kaul. Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis. World Journal of Gastroenterology 2017; 23(37): 6802-6816 doi: 10.3748/wjg.v23.i37.6802
|
| 35 |
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Celia Andrés Juan, Francisco J. Plou, Eduardo Pérez‐Lebeña. From reactive species to disease development: Effect of oxidants and antioxidants on the cellular biomarkers. Journal of Biochemical and Molecular Toxicology 2023; 37(11) doi: 10.1002/jbt.23455
|
| 36 |
Maria Raffaella Petrara, Sarah Shalaby, Elena Ruffoni, Martina Taborelli, Francesco Carmona, Silvia Giunco, Paola Del Bianco, Pierluca Piselli, Diego Serraino, Umberto Cillo, Riccardo Dolcetti, Patrizia Burra, Anita De Rossi. Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.899170
|
| 37 |
C. Nelson Hayes, Peiyi Zhang, Kazuaki Chayama. Hepatocellular Carcinoma. 2019; : 95 doi: 10.15586/hepatocellularcarcinoma.2019.ch5
|
| 38 |
Yuao Wu, Gary Cowin, Shehzahdi S. Moonshi, Huong D.N. Tran, Najma Annuria Fithri, Andrew K. Whittaker, Run Zhang, Hang T. Ta. Engineering chitosan nano-cocktail containing iron oxide and ceria: A two-in-one approach for treatment of inflammatory diseases and tracking of material delivery. Materials Science and Engineering: C 2021; 131: 112477 doi: 10.1016/j.msec.2021.112477
|
| 39 |
Fabio Giannone, Nevena Slovic, Patrick Pessaux, Catherine Schuster, Thomas F. Baumert, Joachim Lupberger. Inflammation-related prognostic markers in resected hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1267870
|
| 40 |
Changfei Li, Mengmeng Deng, Jun Hu, Xin Li, Lizhao Chen, Ying Ju, Junli Hao, Songdong Meng. Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels. Oncotarget 2016; 7(13): 17021 doi: 10.18632/oncotarget.7740
|
| 41 |
Koji Uchino, Ryosuke Tateishi, Naoto Fujiwara, Tatsuya Minami, Masaya Sato, Kenichiro Enooku, Hayato Nakagawa, Yoshinari Asaoka, Yuji Kondo, Haruhiko Yoshida, Kyoji Moriya, Shuichiro Shiina, Masao Omata, Kazuhiko Koike. Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients. Hepatology Research 2016; 46(4): 259 doi: 10.1111/hepr.12517
|
| 42 |
Yu Liu, Yan-Qing Li, Shi-Hao Huang, Yong-Long Li, Jia-Wei Xia, Jun-Shuang Jia, Fang Wei, Jia-Hong Wang, Guan-Qi Dai, Yu-Cai Wang, Xiao-Yan Li, Liu-Xin Han, Xiao-Ling Zhang, Xu-Dong Xiang, Wen-Tao Zhao, Dong Xiao, Xiao-Lin Lin. Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways. Aging 2021; 13(17): 21155 doi: 10.18632/aging.203402
|
| 43 |
Maurizio Montella, Giovanni D’Arena, Anna Crispo, Mario Capunzo, Flavia Nocerino, Maria Grimaldi, Antonio Barbieri, Anna Maria D’Ursi, Mario Felice Tecce, Alfonso Amore, Massimiliano Galdiero, Gennaro Ciliberto, Aldo Giudice. Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma. International Journal of Endocrinology 2015; 2015: 1 doi: 10.1155/2015/854530
|
| 44 |
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli Hemminki, Xinjun Li. Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers. Cancers 2023; 15(12): 3092 doi: 10.3390/cancers15123092
|
| 45 |
Fang Wang, Qi Long, Yu Gong, Longbo Hu, Hong Zhang, Peter Oettgen, Tao Peng. Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells. Cell & Bioscience 2014; 4(1) doi: 10.1186/2045-3701-4-76
|
| 46 |
Daniel Hanna, Kim S. Sugamori, Debbie Bott, Denis M. Grant. The impact of sex on hepatotoxic, inflammatory and proliferative responses in mouse models of liver carcinogenesis. Toxicology 2020; 442: 152546 doi: 10.1016/j.tox.2020.152546
|
| 47 |
Hu Li, Nan-Nan Liu, Jian-Rui Li, Mei-Xi Wang, Jia-Li Tan, Biao Dong, Pei Lan, Li-Min Zhao, Zong-Gen Peng, Jian-Dong Jiang. Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6/STAT3 signaling pathway. Biomedicine & Pharmacotherapy 2022; 150: 113083 doi: 10.1016/j.biopha.2022.113083
|
| 48 |
Lin Huan, Chunyang Bao, Di Chen, Yan Li, Junwei Lian, Jie Ding, Shenglin Huang, Linhui Liang, Xianghuo He. MicroRNA‐127‐5p targets the biliverdin reductase B/nuclear factor‐κB pathway to suppress cell growth in hepatocellular carcinoma cells. Cancer Science 2016; 107(3): 258 doi: 10.1111/cas.12869
|
| 49 |
Qiliu Peng, Shan Ren, Xianjun Lao, Yu Lu, Xiaolian Zhang, Zhiping Chen, Xue Qin, Shan Li. C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Tumor Biology 2014; 35(10): 10169 doi: 10.1007/s13277-014-2334-x
|
| 50 |
Marcos Daniel Mendes Padilha, Francisco Tiago de Vasconcelos Melo, Rogério Valois Laurentino, Andrea Nazaré Monteiro Rangel da Silva, Rosimar Neris Martins Feitosa. Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection. The Brazilian Journal of Infectious Diseases 2025; 29(1): 104468 doi: 10.1016/j.bjid.2024.104468
|
| 51 |
Jun Zhao, Matthew W. Lawless. Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancer. Cytokine 2013; 64(3): 626 doi: 10.1016/j.cyto.2013.09.009
|
| 52 |
Puru Rattan, Carlos D. Minacapelli, Vinod Rustgi. The Microbiome and Hepatocellular Carcinoma. Liver Transplantation 2020; 26(10): 1316 doi: 10.1002/lt.25828
|
| 53 |
Custodia García-Jiménez, Jose Manuel García-Martínez, Ana Chocarro-Calvo, Antonio De la Vieja. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose. Journal of Molecular Endocrinology 2014; 52(1): R51 doi: 10.1530/JME-13-0152
|
| 54 |
Xian Lu, Guanqun Wo, Binghua Li, Chun Xu, Junhua Wu, Chunping Jiang, Jiwu Wei. The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2018; 102: 420 doi: 10.1016/j.biopha.2018.03.099
|
| 55 |
H. Cho, H. Ahn, D. H. Lee, J.‐H. Lee, Y. J. Jung, Y. Chang, J. Y. Nam, Y. Y. Cho, D. H. Lee, E. J. Cho, S. J. Yu, J. M. Lee, Y. J. Kim, J.‐H. Yoon. Entecavir and tenofovir reduce hepatitis B virus‐related hepatocellular carcinoma recurrence more effectively than other antivirals. Journal of Viral Hepatitis 2018; 25(6): 707 doi: 10.1111/jvh.12855
|
| 56 |
Ayman M. Mahmoud, Amr R. Zaki, Manal E. Hassan, Gomaa Mostafa-Hedeab. Commiphora molmol resin attenuates diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis by modulating oxidative stress, inflammation, angiogenesis and Nrf2/ARE/HO-1 signaling. Chemico-Biological Interactions 2017; 270: 41 doi: 10.1016/j.cbi.2017.04.012
|
| 57 |
Kenichiro Enooku, Hayato Nakagawa, Naoto Fujiwara, Mayuko Kondo, Tatsuya Minami, Yujin Hoshida, Junji Shibahara, Ryosuke Tateishi, Kazuhiko Koike. Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47216-2
|
| 58 |
Katharina Zirngibl, Ute M. Moll. p53 further extends its reach. OncoImmunology 2013; 2(5): e24959 doi: 10.4161/onci.24959
|
| 59 |
Hayato Nakagawa. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis. World Journal of Hepatology 2015; 7(17): 2110-2118 doi: 10.4254/wjh.v7.i17.2110
|
| 60 |
J.‐J. Zhang, Y.‐C. Fan, Z.‐H. Zhang, J. Han, L.‐Y. Wang, T. Li, F. Zhang, Y.‐P. Yin, L.‐H. Hu, Y. Yang, F.‐K. Sun, K. Wang. Methylation of suppressor of cytokine signalling 1 gene promoter is associated with acute‐on‐chronic hepatitis B liver failure. Journal of Viral Hepatitis 2015; 22(3): 307 doi: 10.1111/jvh.12286
|
| 61 |
Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis, Alexandros Hardas, Athanasios Pseftogas, Kali Makedou, Athanasios Gargavanis, Thomas Goulopoulos, Stavros Iliadis, Vasileios Papadopoulos, Apostolos Papalois, George Mosialos, Theofilos Poutahidis, Dimitrios Giakoustidis. <p>HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice</p>. OncoTargets and Therapy 2020; : 5575 doi: 10.2147/OTT.S250233
|
| 62 |
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli Hemminki, Xinjun Li. Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers. International Journal of Cancer 2023; 152(6): 1107 doi: 10.1002/ijc.34308
|
| 63 |
Naoto Fujiwara, Hayato Nakagawa, Yotaro Kudo, Ryosuke Tateishi, Masataka Taguri, Takeyuki Watadani, Ryo Nakagomi, Mayuko Kondo, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Yuji Kondo, Yoshinari Asaoka, Yasuo Tanaka, Kuni Ohtomo, Shuichiro Shiina, Kazuhiko Koike. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. Journal of Hepatology 2015; 63(1): 131 doi: 10.1016/j.jhep.2015.02.031
|
| 64 |
Alex José de Melo Silva, Juliana Ellen de Melo Gama, Cleonilde Maria de Nascimento, Jessica Paula Lucena, Cicero Jadson da Costa, Camila Juliet Barbosa Fernandes, Danielle Maria Nascimento Moura, Helotonio Carvalho, Sheilla Andrade de Oliveira. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 85 doi: 10.1007/16833_2022_37
|
| 65 |
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli Hemminki, Xinjun Li. Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden. Cancer 2023; 129(8): 1227 doi: 10.1002/cncr.34663
|
| 66 |
Peng Li, Wei Huang, Feng Wang, Ye-Fang Ke, Lin Gao, Ke-Qing Shi, Meng-Tao Zhou, Bi-Cheng Chen. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20180464
|
| 67 |
Badr Alzahrani, Tristan J. Iseli, Lionel W. Hebbard. Non-viral causes of liver cancer: Does obesity led inflammation play a role?. Cancer Letters 2014; 345(2): 223 doi: 10.1016/j.canlet.2013.08.036
|
| 68 |
N. V. Baginskaya, E. V. Kashina, M. Yu. Shamanina, S. I. Ilnitskaya, V. I. Kaledin, V. A. Mordvinov. Correlation of susceptibility to ortho-aminoazotoluene-induced hepatocarcinogenesis with Car and Ahr signaling pathway activation in mice. Russian Journal of Genetics: Applied Research 2016; 6(4): 463 doi: 10.1134/S2079059716040043
|
| 69 |
Moritz Kleine, Tim Worbs, Harald Schrem, Florian W. R. Vondran, Alexander Kaltenborn, Jürgen Klempnauer, Reinhold Förster, Christine Josenhans, Sebastian Suerbaum, Hüseyin Bektas, Partha Mukhopadhyay. Helicobacter hepaticus Induces an Inflammatory Response in Primary Human Hepatocytes. PLoS ONE 2014; 9(6): e99713 doi: 10.1371/journal.pone.0099713
|
| 70 |
Ki-Choon Choi, Jung-Min Hwang, Sung-Jun Bang, Young-Ok Son, Beom-Tae Kim, Dong-Hern Kim, Seung-Ah Lee, Minseon Chae, Da Hye Kim, Jeong-Chae Lee. Methanol extract of the aerial parts of barley (Hordeum vulgare) suppresses lipopolysaccharide-induced inflammatory responsesin vitroandin vivo. Pharmaceutical Biology 2013; 51(8): 1066 doi: 10.3109/13880209.2013.768274
|
| 71 |
Camilla Volponi, Aurora Gazzillo, Eduardo Bonavita. The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network. Cancers 2022; 14(24): 6151 doi: 10.3390/cancers14246151
|
| 72 |
Masanori Oshi, Kohei Chida, Arya Mariam Roy, Gabriella Kim Mann, Nan An, Li Yan, Itaru Endo, Kazuaki Takabe. Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome. Hepatology International 2024; 18(4): 1299 doi: 10.1007/s12072-024-10678-2
|
| 73 |
Jiaqi LIU, Chi Tim LEUNG, Luyun LIANG, Yuqin WANG, Jian CHEN, Keng Po LAI, William Ka Fai TSE. Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis. Cancers 2022; 14(14): 3547 doi: 10.3390/cancers14143547
|
| 74 |
Jen-Pi Tsai, Pei-Ching Hsiao, Shun-Fa Yang, Shu-Ching Hsieh, Da-Tian Bau, Chu-Liang Ling, Chun-Li Pai, Yi-Hsien Hsieh, Xin-Yuan Guan. Licochalcone A Suppresses Migration and Invasion of Human Hepatocellular Carcinoma Cells through Downregulation of MKK4/JNK via NF-κB Mediated Urokinase Plasminogen Activator Expression. PLoS ONE 2014; 9(1): e86537 doi: 10.1371/journal.pone.0086537
|
| 75 |
SHUKAI XIA, JUAN MA, XIAOMING BAI, HAI ZHANG, SHANYU CHENG, MIN ZHANG, LI ZHANG, MINGZHAN DU, YIPIN WANG, HAI LI, RONG RONG, FENG SHI, QINYI YANG, JING LENG. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway. Oncology Reports 2014; 32(4): 1521 doi: 10.3892/or.2014.3393
|
| 76 |
Hayato Nakagawa, Yuki Hayata, Satoshi Kawamura, Tomoharu Yamada, Naoto Fujiwara, Kazuhiko Koike. Lipid Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 2018; 10(11): 447 doi: 10.3390/cancers10110447
|
| 77 |
Kari Hemminki, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli Hemminki. Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries. JHEP Reports 2022; 4(12): 100602 doi: 10.1016/j.jhepr.2022.100602
|
| 78 |
Dong Hwi Kim, Hyo Jeong Yong, Sunam Mander, Huong Thi Nguyen, Lan Phuong Nguyen, Hee-Kyung Park, Hyo Kyeong Cha, Won-Ki Kim, Jong-Ik Hwang. SP-8356, a (1S)-(-)-Verbenone Derivative, Inhibits the Growth and Motility of Liver Cancer Cells by Regulating NF-κB and ERK Signaling. Biomolecules & Therapeutics 2021; 29(3): 331 doi: 10.4062/biomolther.2020.200
|
| 79 |
Weiqi Xu, Jun Yu, Vincent Wai-Sun Wong. Mechanism and prediction of HCC development in HBV infection. Best Practice & Research Clinical Gastroenterology 2017; 31(3): 291 doi: 10.1016/j.bpg.2017.04.011
|
| 80 |
Nana Chen, Naomi Nishio, Sachiko Ito, Yuriko Tanaka, Yang Sun, Ken-ichi Isobe. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model. Cancer Immunology, Immunotherapy 2015; 64(6): 777 doi: 10.1007/s00262-015-1690-8
|
| 81 |
Junwei Hou, Xin Li, Changfei Li, Lu Sun, Yulai Zhao, Jingmin Zhao, Songdong Meng. Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR. Molecular Oncology 2015; 9(7): 1312 doi: 10.1016/j.molonc.2015.03.004
|
| 82 |
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Nima Rezaei, Fatemeh Fallah, Davood Bashash. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies. Cell Biochemistry and Function 2024; 42(5) doi: 10.1002/cbf.4098
|
| 83 |
Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment. Vaccines 2021; 9(5): 532 doi: 10.3390/vaccines9050532
|
| 84 |
Adriana Ahumada, Laura Rayón, Clara Usón, Rafael Bañares, Sonia Alonso Lopez. Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?. World Journal of Gastroenterology 2021; 27(40): 6737-6749 doi: 10.3748/wjg.v27.i40.6737
|
| 85 |
Ahmed Olatunde, Manisha Nigam, Rahul Kunwar Singh, Abhaya Shikhar Panwar, Abdulwahab Lasisi, Fahad A. Alhumaydhi, Vijay Jyoti kumar, Abhay Prakash Mishra, Javad Sharifi-Rad. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02202-5
|
| 86 |
Songdong Meng, Zihai Li. Heat Shock Proteins in the Immune System. 2018; : 123 doi: 10.1007/978-3-319-69042-1_7
|
| 87 |
Misako Nagasaka, Bayan Al-Share, Yusra F. Shao, Rachel Sexton, Mohammed Najeeb Al Hallak, Asfar S. Azmi, Ammar Sukari. Comprehensive Gut Microbiota. 2022; : 339 doi: 10.1016/B978-0-12-819265-8.00047-4
|
| 88 |
Jia-Zhu Fang, Chong Li, Xiao-Yan Liu, Tao-Tao Hu, Zu-Sen Fan, Ze-Guang Han, Diego Calvisi. Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma. PLOS ONE 2015; 10(11): e0143042 doi: 10.1371/journal.pone.0143042
|
| 89 |
Li Wang, Deze Zhao, Kang Qin, Faisal UL Rehman, Xiaochun Zhang. Effect and biomarker of Nivolumab for non–small-cell lung cancer. Biomedicine & Pharmacotherapy 2019; 117: 109199 doi: 10.1016/j.biopha.2019.109199
|
| 90 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_5-1
|
| 91 |
Gian Piero Guerrini, Domenico Pinelli, Fabrizio Di Benedetto, Elena Marini, Vittorio Corno, Michela Guizzetti, Alessandro Aluffi, Marco Zambelli, Stefano Fagiuoli, Maria Grazia Lucà, Alessandro Lucianetti, Michele Colledan. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation. Surgical Oncology 2016; 25(4): 419 doi: 10.1016/j.suronc.2015.09.003
|
| 92 |
Bastian Höchst, Frank A. Schildberg, Pia Sauerborn, Yvonne A. Gäbel, Heidrun Gevensleben, Diane Goltz, Lukas C. Heukamp, Andreas Türler, Matthias Ballmaier, Friederike Gieseke, Ingo Müller, Jörg Kalff, Christian Kurts, Percy A. Knolle, Linda Diehl. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. Journal of Hepatology 2013; 59(3): 528 doi: 10.1016/j.jhep.2013.04.033
|
| 93 |
Yikai Wang, Le Ma, Pengjun Xue, Bianni Qin, Ting Wang, Bo Li, Lina Wu, Liyan Zhao, Xiongtao Liu, Antonio Giovanni Solimando. Construction and Analysis of Hepatocellular Carcinoma Prognostic Model Based on Random Forest. Canadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/6707698
|
| 94 |
Abdullah Alyoussef, Mohammed M H Al-Gayyar. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Biomedicine & Pharmacotherapy 2018; 103: 362 doi: 10.1016/j.biopha.2018.04.060
|
| 95 |
Shigeyuki Kurosaki, Hayato Nakagawa, Yuki Hayata, Satoshi Kawamura, Yuki Matsushita, Tomoharu Yamada, Koji Uchino, Yoku Hayakawa, Nobumi Suzuki, Masahiro Hata, Mayo Tsuboi, Hiroto Kinoshita, Yasuo Tanaka, Takuma Nakatsuka, Yoshihiro Hirata, Keisuke Tateishi, Kazuhiko Koike. Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis. JHEP Reports 2021; 3(4): 100315 doi: 10.1016/j.jhepr.2021.100315
|
| 96 |
Chun-Meng Jiang, Chun-Wen Pu, Ya-Hui Hou, Zhe Chen, Mohammed Alanazy, Lionel Hebbard. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World Journal of Gastroenterology 2014; 20(44): 16464-16473 doi: 10.3748/wjg.v20.i44.16464
|
| 97 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 121 doi: 10.1007/978-3-319-26956-6_5
|
| 98 |
Qing-Qi Ren, Shun-Jun Fu, Qiang Zhao, Zhi-Yong Guo, Fei Ji, Mao-Gen Chen, Lin-Wei Wu, Xiao-Shun He. Prognostic value of preoperative peripheral monocyte count in patients with hepatocellular carcinoma after liver transplantation. Tumor Biology 2016; 37(7): 8973 doi: 10.1007/s13277-015-4758-3
|
| 99 |
Min Zhao, Shimiao Tang, Junchi Xin, Yingliang Wei, Dongyan Liu. Reactive oxygen species induce injury of the intestinal epithelium during hyperoxia. International Journal of Molecular Medicine 2017; doi: 10.3892/ijmm.2017.3247
|
| 100 |
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
|
| 101 |
Tong Ji, Gaofeng Li, Jiang Chen, Jie Zhao, Xi Li, Hui Lin, Xiujun Cai, Yong Cang. Distinct role of interleukin-6 and tumor necrosis factor receptor-1 in oval cell- mediated liver regeneration and inflammation-associated hepatocarcinogenesis. Oncotarget 2016; 7(41): 66635 doi: 10.18632/oncotarget.11365
|
| 102 |
Meixian Xiang, Hanwen Su, Yajing Hu, Yun Hu, Tianming Yang, Guangwen Shu. Chemical composition of total flavonoids from Salvia chinensia Benth and their pro-apoptotic effect on hepatocellular carcinoma cells: Potential roles of suppressing cellular NF-κB signaling. Food and Chemical Toxicology 2013; 62: 420 doi: 10.1016/j.fct.2013.09.008
|
| 103 |
Song Xu, Wenquan Zhou, Jingping Ge, Zhengyu Zhang. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8415
|
| 104 |
Bo Peng, Fan Liu, Rong Han, George Luo, Terry Cathopoulis, Kun Lu, Xiao Li, Ling Yang, Guo-Yan Liu, Jian-Chun Cai, Song-Lin Shi. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells. The International Journal of Biochemistry & Cell Biology 2015; 66: 45 doi: 10.1016/j.biocel.2015.07.007
|
| 105 |
Malatee Tayeh, Sirinun Nilwarangoon, Wilawan Mahabusarakum, Ramida Watanapokasin. Anti-metastatic effect of rhodomyrtone from Rhodomyrtus tomentosa on human skin cancer cells. International Journal of Oncology 2017; 50(3): 1035 doi: 10.3892/ijo.2017.3845
|
| 106 |
Gaiping Wang, Liya Cheng, Meng Chen, Congcong Zhao, Mingxin Gao, Tiantian Huang, Peipei Chu, Cunshuan Xu. Comparative Analysis of Expression Profiles of Reg Signaling Pathways-Related Genes Between AHF and HCC. Biochemical Genetics 2019; 57(3): 382 doi: 10.1007/s10528-018-9900-7
|
| 107 |
Jihan Huang, Wei Guo, Fan Cheung, Hor-Yue Tan, Ning Wang, Yibin Feng. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma. The American Journal of Chinese Medicine 2020; 48(01): 161 doi: 10.1142/S0192415X20500093
|